loader
Please Wait
Applying Filters...

Metrochem API Private Limited Metrochem API Private Limited

X

End Use API - CAS 22972-51-6 manufacturers and suppliers on PharmaCompass

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Embio Limited (1)

02 SCI PHARMTECH (2)

URL Supplier Web Content
22972-51-6
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salt...
Embio is today the world’s second largest Integrated manufacturer of Ephedrine and Pseudoephedrine salts Embio’s facility at Mahad ( 180 Kms from Bombay by road ) has been audited and approved by the Australian TGA, and the US FDA Embio has also been granted the Certificate of Suitability ( CoS ) for its Pseudoephedrine HCl
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
22972-51-6
Cannabidiol
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 10...
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 100 years. It is engaged in the research and development, production and marketing of intermediates, APIs and specialty chemicals. The products are exported to major pharmaceutical manufacturers in Europe, the United States, and Japan. Affirmed by customers. At present, the main shareholder of the company is the Sanshang Bank Group. The strong shareholder lineup and excellent management team have made the company's performance grow year by year, and it was listed on the Taiwan Stock Exchange in 2004.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
22972-51-6
Tetrahydrocannabinol
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 10...
The company was established in Taiwan in 1987 by the Swiss Siegfried Group with a history of more than 100 years. It is engaged in the research and development, production and marketing of intermediates, APIs and specialty chemicals. The products are exported to major pharmaceutical manufacturers in Europe, the United States, and Japan. Affirmed by customers. At present, the main shareholder of the company is the Sanshang Bank Group. The strong shareholder lineup and excellent management team have made the company's performance grow year by year, and it was listed on the Taiwan Stock Exchange in 2004.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY